A woman in Bangkok was hospitalized with severe side effects after receiving an unregistered slimming injection at an aesthetic clinic, where non-medical staff allegedly administered the product. Thai authorities have ordered the clinic to suspend operations for 15 days and are pursuing criminal and administrative penalties. The case underscores critical supply-chain risks for overseas buyers sourcing injectables and clinic services in Thailand.
Incident details
On May 29, the victim visited the clinic seeking weight-loss treatment and initially inquired about the well-known drug Mounjaro. After expressing a preference for a lower-side-effect option, clinic staff recommended "VitaPeptix NOVOTRIMPLUS+", claiming minimal adverse effects. She received the injection that day. By May 30, she experienced severe discomfort, and on May 31, her condition deteriorated, requiring emergency hospitalization in Sai Mai district.
Regulatory investigation findings
A joint probe by Thailand's Health Service Support Department, Food and Drug Administration (FDA), and Central Investigation Bureau (CIB) revealed multiple violations. The "VitaPeptix NOVOTRIMPLUS+" product was never registered with Thai health authorities, making it an illegal counterfeit drug. Additionally, non-physician staff performed the injection, violating the Hospital Act's quality and safety standards. The clinic had also moved from its registered address without notifying regulators, and drug packaging lacked required labels including clinic name, address, and expiration dates.
Enforcement actions
On June 4, authorities formally ordered the clinic to cease operations for 15 days. Legal proceedings are underway against the clinic's owner and involved personnel. The victim's husband publicly thanked enforcement agencies for their swift response and confirmed plans to pursue full legal action and compensation.
What buyers should watch
This case highlights critical due diligence points for overseas importers and distributors sourcing aesthetic injectables or partnering with Thai clinics. Verify that all products carry valid FDA Thailand registration numbers. Ensure clinics operate from their registered address and employ licensed medical professionals for all injection procedures. Check that packaging complies with local labeling requirements. Non-compliance can lead to severe health risks, legal liability, and supply-chain disruptions.
Source: Read the original report | Published: June 05, 2026